tiprankstipranks
MicroPort Scientific Corp (MCRPF)
:MCRPF
Holding MCRPF?
Track your performance easily

MicroPort Scientific (MCRPF) Stock Price & Analysis

8 Followers

MCRPF Stock Chart & Stats


Bulls Say, Bears Say

Bulls Say
Market LeadershipMicroPort is a global leading medical device maker focused on minimally invasive interventional devices, ranking 1st in China and top 5 globally in key segments.
SpecializationMicroPort is a global leading medical device maker focused on minimally invasive interventional devices, ranking 1st in China and top 5 globally for its cardiovascular and cardiac rhythm management segments.
ValuationNegatives are likely priced in with the price-to-sales ratio at 0.9 standard deviations below the 5-year average.
Bears Say
Financial PerformanceThe company's net loss forecast has been widened significantly due to harsh price cuts from bulk purchases, affecting profitability.
Market RisksThere are potential restrictions on bidding in EU public hospital tenders, putting a significant portion of the group's sales at risk.
Research And DevelopmentSignificant cuts in R&D expenses are expected, delaying the progress of new products and reducing future sales growth potential.
---

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

1.65%96.45%
Insiders
― Other Institutional Investors
96.45% Public Companies and
Individual Investors

MCRPF FAQ

What was MicroPort Scientific Corp’s price range in the past 12 months?
MicroPort Scientific Corp lowest stock price was $0.55 and its highest was $1.22 in the past 12 months.
    What is MicroPort Scientific Corp’s market cap?
    MicroPort Scientific Corp’s market cap is $1.30B.
      When is MicroPort Scientific Corp’s upcoming earnings report date?
      MicroPort Scientific Corp’s upcoming earnings report date is Mar 26, 2025 which is in 66 days.
        How were MicroPort Scientific Corp’s earnings last quarter?
        MicroPort Scientific Corp released its earnings results on Aug 30, 2024. The company reported -$0.056 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.056.
          Is MicroPort Scientific Corp overvalued?
          According to Wall Street analysts MicroPort Scientific Corp’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
            Does MicroPort Scientific Corp pay dividends?
            MicroPort Scientific Corp pays a Annually dividend of $0.006 which represents an annual dividend yield of N/A. See more information on MicroPort Scientific Corp dividends here
              What is MicroPort Scientific Corp’s EPS estimate?
              MicroPort Scientific Corp’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does MicroPort Scientific Corp have?
              MicroPort Scientific Corp has 1,846,725,700 shares outstanding.
                What happened to MicroPort Scientific Corp’s price movement after its last earnings report?
                MicroPort Scientific Corp reported an EPS of -$0.056 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 5%.
                  Which hedge fund is a major shareholder of MicroPort Scientific Corp?
                  Currently, no hedge funds are holding shares in MCRPF
                  ---

                  MicroPort Scientific Stock Smart Score

                  Company Description

                  MicroPort Scientific Corp

                  MicroPort Scientific Corp. is an investment holding company, which engages in the research and development, manufacture and distribution of medical devices. It operates through the following segments: Orthopedics Devices Business; Cardiovascular Devices Business; Endovascular Devices Business; Electrophysiology Devices Business; Neurovascular Devices Business; Surgical Management Business; and Diabetes Care and Endocrinal Business. The company was founded by Zhaohua Chang in 1998 and is headquartered in Shanghai, China.
                  ---

                  MCRPF Stock 12 Month Forecast

                  Average Price Target

                  $1.03
                  ▲(41.10% Upside)
                  {"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"4":"$4","-1":"-$1","0.25":"$0.25","1.5":"$1.5","2.75":"$2.75"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":1.03,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$1.03</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1.03,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$1.03</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1.03,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$1.03</span>\n  </div></div>","useHTML":true}}],"tickPositions":[-1,0.25,1.5,2.75,4],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2022","6":"Sep<br/>2023","9":"May<br/>2024","12":"Nov<br/>2024","25":"Nov<br/>2025"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.85,0.8638461538461538,0.8776923076923077,0.8915384615384615,0.9053846153846153,0.9192307692307692,0.9330769230769231,0.946923076923077,0.9607692307692308,0.9746153846153847,0.9884615384615385,1.0023076923076923,1.0161538461538462,{"y":1.03,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.85,0.8638461538461538,0.8776923076923077,0.8915384615384615,0.9053846153846153,0.9192307692307692,0.9330769230769231,0.946923076923077,0.9607692307692308,0.9746153846153847,0.9884615384615385,1.0023076923076923,1.0161538461538462,{"y":1.03,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.85,0.8638461538461538,0.8776923076923077,0.8915384615384615,0.9053846153846153,0.9192307692307692,0.9330769230769231,0.946923076923077,0.9607692307692308,0.9746153846153847,0.9884615384615385,1.0023076923076923,1.0161538461538462,{"y":1.03,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":2.06,"date":1654041600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":2.92,"date":1656633600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":2.34,"date":1659312000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":2.34,"date":1659312000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":3.43,"date":1675209600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1.97,"date":1690848000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1.72,"date":1693526400000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.95,"date":1709251200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.84,"date":1711929600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.8,"date":1714521600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.63,"date":1725148800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.99,"date":1727740800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.85,"date":1730419200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Boston Scientific
                  Medtronic
                  Zimmer Biomet Holdings
                  Edwards Lifesciences
                  Stryker
                  Intuitive Surgical

                  Best Analysts Covering MCRPF

                  1 Year
                  Derek ChoiJ.P. Morgan
                  Not Ranked
                  1 Year Success Rate
                  0/1 ratings generated profit
                  0%
                  1 Year Average Return
                  -20.30%
                  reiterated a buy rating 2 months ago
                  Copying Derek Choi's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -20.30% per trade.
                  Popular Stocks
                  ---
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis